sorin REPLY DR Manual De Implante página 8

Marcapasos cardiaco bicameral con adaptación de frecuencia
Tabla de contenido

Publicidad

Idiomas disponibles
  • MX

Idiomas disponibles

i Pulse width ................................................................. 19
i Sensitivity ................................................................... 19
i Pacing and sensing polarities ..................................... 19
7.4. Refractory periods ............................................................ 20
i Absolute refractory periods ........................................ 20
i Committed period ....................................................... 20
i Automatic AV delay .................................................... 20
i AVD Paced/Sensed Offset ......................................... 21
7.5. Rate response .................................................................. 21
7.6. Therapeutic improvements .............................................. 22
i SafeR mode ................................................................ 22
i Dplus mode ................................................................ 22
i Rate acceleration........................................................ 23
i AV delay shortening ................................................... 23
i Rest rate ..................................................................... 23
i Rate smoothing .......................................................... 24
7.7. Managing atrial arrhythmias (AA) .................................... 25
i Preventing AA: Overdrive ........................................... 25
i Preventing AA: Post extrasystolic pause suppression25
i Preventing AA: Acceleration on PAC ......................... 26
7.8. Optimizing operation ........................................................ 27
i Automatic detection of implantation ........................... 27
i Autosensing ................................................................ 28
i Ventricular Auto-threshold .......................................... 29
i Anti-PMT protection .................................................... 29
8. Patient follow-up ...................................................................... 30
8.1. Follow-up recommendations ............................................ 30
8.2. Elective Replacement Indicator (ERI) .............................. 30
8.3. Explant ............................................................................. 31
8.4. Programmer tests ............................................................ 32
8.5. Interrogating the memories (AIDA+) ................................ 32
8.6. Pacemaker identification .................................................. 33

Hide quick links:

Publicidad

Tabla de contenido
loading

Tabla de contenido